The impact of peritoneal metastases in epithelial ovarian cancer with positive nodes

International Journal of Gynecological Cancer

Volumn 21, Issue 8, 2011, Pages 1375-1379

  Pereira, Augusto ^a,b   Magrina, Javier F ^a   Magtibay, Paul M ^a   Pérez Medina, Tirso ^b   Fernández, Ana ^c   Peregrin, Irene ^d  

^a MAYO CLINIC   (United States)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d Division of Gynecologic Surgery   (Spain)

Author keywords

Complete debulking; Epithelial ovarian cancer; Extent of peritoneal disease; Incomplete debulking; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVARY CANCER; OVERALL SURVIVAL; PERITONEUM METASTASIS; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; CARCINOMA; METASTASIS; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84857478331     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822fa849     Document Type: Article

References (14)

1. Cliby WA, Aletti GD, Wilson TO, et al. Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006;103:781-782.
2. FIGO Cancer Committee. Staging announcement. Gynecol Oncol. 1986;25:383.
3. Aletti GD, Dowdy SC, Podratz KC, et al. Analysis of factors impacting operability in stage IVovarian cancer: rationale use of a triage system. Gynecol Oncol. 2007;105:84-89. (Pubitemid 46441445)
4. Aletti GD, Podratz KC, Cliby WA, et al. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment. Gynecol Oncol. 2009;112:22-27.
5. Pereira A, Magrina JF, Rey V, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol. 2007;105:604-608. (Pubitemid 46734179)
6. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley-Interscience; 2000.
7. Aletti GD, Dowdy SC, Gostout BS, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006;107:77-85.
8. Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Ontology Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2007;106:69-74.
9. Aletti GD, Gostout BS, Podratz KC, et al. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol. 2006;100:33-37. (Pubitemid 41815046)
10. Hoskins WJ, Bundy BN, Thigpen JT, et al. The Gynecologic Oncology Group (GOG). The influence of cytoreductive surgery on progression free interval (PFI) and survival (S) in optimal (<1cm) stage III epithelial ovarian cancer (EOC). Gynecol Oncol. 1992;45:76. SGO #2.
11. Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease after primary cytoreductive surgery on survival in patients with suboptimal residual epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1994;170:974-980. (Pubitemid 24157907)
12. Eisenkop SM, Nalick RH, Wang HJ, et al. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol. 1993;51:224-229. (Pubitemid 24020369)
13. Eisenkop SM, Spirtos NM. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol. 2001;82:489-497. (Pubitemid 32826449)
14. Colombo PE, Mourregot A, Fabbro M, et al. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC 266 and IV patients. Eur J Surg Oncol. 2008;18:135-143.